Dermal Fillers
YVOIRE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 11239
Yvoire Y-Solution 360
In stock
Volume
1 x 1 mL
Laboratory
LG Chem
Origin
Südkorea
Indication
Anti-ageing correction with flexible projection
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler at 12 mg/mL (1.2%) with 0.3% lidocaine, manufactured in South Korea as part of the YVOIRE Y-Solution range. The manufacturer describes the range as built on a synergy between elasticity and cohesion, giving the gel spring-like characteristics that provide flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed. Shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock. Intended for professional use by qualified practitioners only.
Key Benefits of Yvoire Y-Solution 360
- Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides flexible projection and is designed to resist the dynamics of facial expression
- Cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine, the lightest gel in the Yvoire range
- Built on the manufacturer's S-HICE cross-linking process
- Supports anti-ageing aesthetic treatment approaches
- Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
- Supplied with two Terumo thin-wall 29G needles
Indications and Professional Use
Main indications
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring flexibility and cohesion
Professional use
Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. Injection technique and volume per treatment area are determined by the practitioner.
Treatment areas
- Face
Patient profile
Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is the lightest gel in the whole Yvoire range, well below the 20 to 22 mg/mL of the Volume and Contour references, so patients seeking structural contouring of the chin or nose, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.
How Yvoire Y-Solution 360 Works
Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL (1.2%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is the lightest gel in the Yvoire range, against 20 to 22 mg/mL for the Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.
Why Order From Allpara
Allpara offers genuine, verified YVOIRE products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
What is in Yvoire Y-Solution 360?
Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
How does Yvoire Y-Solution 360 differ from the 540 and 720?
The 360 is 12 mg/mL with 29G needles. The 540 and 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.
More from LG Chem
Clinic alternatives
Mesotherapy
Skin Boosters
/ Recently viewed
Pick up where you left off
Yvoire Y-Solution 360
In stock
CE Marked
Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler at 12 mg/mL (1.2%) with 0.3% lidocaine, manufactured in South Korea as part of the YVOIRE Y-Solution range. The manufacturer describes the range as built on a synergy between elasticity and cohesion, giving the gel spring-like characteristics that provide flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed. Shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock. Intended for professional use by qualified practitioners only.
Key Benefits of Yvoire Y-Solution 360
- Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides flexible projection and is designed to resist the dynamics of facial expression
- Cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine, the lightest gel in the Yvoire range
- Built on the manufacturer's S-HICE cross-linking process
- Supports anti-ageing aesthetic treatment approaches
- Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
- Supplied with two Terumo thin-wall 29G needles
Indications and Professional Use
Main indications
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring flexibility and cohesion
Professional use
Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. Injection technique and volume per treatment area are determined by the practitioner.
Treatment areas
- Face
Patient profile
Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is the lightest gel in the whole Yvoire range, well below the 20 to 22 mg/mL of the Volume and Contour references, so patients seeking structural contouring of the chin or nose, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.
How Yvoire Y-Solution 360 Works
Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL (1.2%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is the lightest gel in the Yvoire range, against 20 to 22 mg/mL for the Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.
Why Order From Allpara
Allpara offers genuine, verified YVOIRE products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
What is in Yvoire Y-Solution 360?
Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
How does Yvoire Y-Solution 360 differ from the 540 and 720?
The 360 is 12 mg/mL with 29G needles. The 540 and 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.
More from LG Chem
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.